Find the latest pharmaceutical market place for formulations enquiry about Imatinib Mesylate on PharmaCompass.com.

Various Finished Formulation needed in China [ENA19990]

A CDMO that focuses on the development of various finished formulations, including creams, emulsions, liquids, solutions, films, and OSDs is looking for various finished formulations for commercial purposes. The required quantity is 20,000 boxes - 30,000 boxes.
1. Capecitabine (500 mg) Tablets or Capsules
2. Dasatinib (50 mg) Tablets or Capsules
3. Enzalutamide (160 mg) Tablets or Capsules
4. Nilotinib (200 mg) Tablets or Capsules
5. Imatinib Mesylate (400 mg) Tablets or Capsules
6. Midostaurin (25 mg) Tablets or Capsules
7. Sunitinib Malate (50 mg) Tablets or Capsules
8. Tofacitinib XR (11 mg) Tablets or Capsules
9. Pazopanib (400 mg) Tablets or Capsules
10. Adagrasib (200 mg) Tablets or Capsules
11. Apalutamide (60 mg) Tablets or Capsules
12. Fingolimod (0.5 mg) Tablets or Capsules
13. Nintedanib (150 mg) Tablets or Capsules
14. Valganciclovir (450 mg) Tablets or Capsules

Reply

16 Jul 2024

Tender// Various Finished Dosage Formulations needed in Bulgaria [ENA18461]

Complex Oncology Center - Ruse Ltd is looking for supplies of Various Finished Dosage Formulations for commercial purposes. The deadline is 23-Nov-2023.
1. Capecitabine (500 mg) Film Coated Tablets. The required quantity is 57,600 units.
2. Imatinib (100 mg) Film Coated Tablets. The required quantity is 14,600 units.

Reply

27 Oct 2023

Tender// Various Finished Dosage Formulations needed in Belgium [ENA16273]

Vivalia is looking for supplies of Various Finished Dosage Formulations for commercial purposes. The deadline is 23-Feb-2023.
1. Capecitabine (500 mg) Tablets. The required quantity is 18,120 units.
2. Imatinib (100 mg) Tablets. The required quantity is 4,081 units.

Reply

02 Feb 2023

Tender// Various Finished Dosage Formulations needed in Belgium [ENA16231]

Vivalia is looking for supplies of Various Finished Dosage Formulations for commercial purposes. The deadline is 16-Feb-2023.
1. Capecitabine (500 mg) Tablets. The required quantity is 18,120 units.
2. Imatinib (100 mg) Tablets. The required quantity is 4,081 units.
3. Etoposide (100 mg/ 5 ml) Injections. The required quantity is 1,388 units.

Reply

28 Jan 2023

Tender// Various Finished Dosage Formulations needed in Belgium [ENA16105]

Vivalia is looking for supplies of Various Finished Dosage Formulations for commercial purposes. The deadline is 16-Feb-2023.
1. Capecitabine (500 mg) Tablets. The required quantity is 18,120 units.
2. Imatinib (100 mg) Tablets. The required quantity is 4,081 units.

Reply

17 Jan 2023

Various Finished Formulations needed in Spain [ENA15729]

A company based in Switzerland that provides consultancy services to the pharmaceutical industry is looking for suppliers of Various Finished Formulations for commercial purposes. The suppliers must support this enquiry with dossier & EU-MA.
1. Capecitabine (500 mg & 150 mg) Tablets
2. Imatinib (100 mg & 400 mg) Tablets

Reply

03 Dec 2022

Tender// Various Finished Dosage Formulations needed in Bulgaria [ENA15105]

Spetsializirana Bolnitsa Za Aktivno Lechenie Na Onkologichni Zabolyavaniya "Prof. Dr Marin Mushmov" Eood is looking for supplies of Various Finished Dosage Formulations for commercial purpose. The deadline is 17-Oct-2022.
1. Paclitaxel (100 mg) Powder for Dispersion for Infusions. The required quantity is 190,000 units.
2. Imatinib (100 mg) Film Coated Tablets. The required quantity is 1,360,800 units.

Reply

23 Sep 2022

Various Finished Dosage Formulations needed in Vietnam [ENA12485]

A company that deals in the distribution of a wide range of products in allopathic formulations, herbal formulations, nutraceuticals, vaccines and orthopedic implants is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The required quantity is 500,000 units for each.
1. Glipizide (5 mg) Tablets
2. Glucosamine (1500 mg) Powder for Oral Solution
3. Hydroxypropyl Methyl Cellulose (3 mg/ 3 ml) Eye drops
4. Ibuprofen (200 mg) + Codeine (12.8 mg) Film coated Tablets
5. Imatinib (100 mg & 400 mg) Tablets

Reply

22 Jan 2022

Russia-big Flag

Tender// Imatinib (100 mg) Capsules needed in Russia [ENA12100]

Department Of State Order Of Yamalo-Nenets Autonomous District is looking for supplies of Imatinib (100 mg) Capsules for commercial purpose. The required quantity is 7,440 units. The deadline is 17-Jan-2022.

Reply

13 Dec 2021

Various Finished Dosage Formulations needed in Bosnia [ENA10531]

A company based in India that acts as a one-stop solution provider for all your market access & market activation needs is looking for suppliers of Various Finished Dosage Formulations for commercial purposes.
1. Carboplatin (150 mg, 450 mg & 600 mg) Vials. The required quantity is 11,000 units for each.
2. Cyclophosphamide (200 mg, 500 mg, 1000 mg) Injections. The required quantity is 23,000 units, 9,000 units and 9,000 units respectively.
3. 5 Fluorouracil (250 mg/ 5 ml & 500 mg/ 10 ml) Injections. The required quantity is 16,500 units and 26,600 units respectively.
4. Granisetron (1 ml & 3 ml) Vials. The required quantity is 43,000 units and 55,400 units respectively.
5. Zoledronic Acid (4 mg) Vials. The required quantity is 1,10,000 units.
6. Letrozole (2.5 mg) Tablets. The required quantity is 17,05,000 units.
7. Imatinib Mesylate (100 mg) Tablets. The required quantity is 2,73,000 units.

Reply

29 May 2021

Tender// Various Finished Dosage Formulations needed in Bulgaria [ENA09741]

Voennomeditsinska akademiya is looking for supplies of Various Finished Dosage Formulations. The deadline is 12-March-2021.
1. Tranexamic acid (100 mg/ ml in 10 ml) Solution for Injection. The required quantity is 3,000 units.
2. Nifuratel, Nystatin (500 mg/ 200000 IU/ g) Vaginal Soft Capsules. The required quantity is 300 units.
3. Imatinib (100 mg or 400 mg) Tablets. The required quantity is 6,000,000 units.
4. Cefoperazone/ Sulbactam (1 g/ 1 g) Solution for Injection. The required quantity is 60,000 units.

Reply

16 Feb 2021

Tender// Various Finished Dosage Formulations needed in Bulgaria [ENA09450]

Specialized hospital for active treatment of oncological diseases "Dr Marko Antonov Markov - Varna" EOOD is looking for supplies of Various Finished Dosage Formulations. The deadline is 24-Jan-2021.
1. Imatinib (100 mg) Film-Coated Tablets. The required quantity is 38,400 units.
2. Filgrastim (300 mcg) Solution for Injection. The required quantity is 1,500 units.
3. Irinotecan anhydrous free base (43 mg) Concentrate for Dispersion for Infusion. The required quantity is 100 units.

Reply

09 Jan 2021

unitedkingdom_new Flag

Tender// Invitation to offer for NHS National Pharmaceuticals in the United Kingdom [ENA09122]

Invitation to offer for NHS National Pharmaceuticals in the United Kingdom. The deadline is 08-Dec-2020.
1. Fulvestrant (250 mg/ 5 ml) Injection Pre-Filled Syringe. The required quantity is 26,120 units.
2. Darunavir (400 mg & 600 mg) Tablets. The required quantity is 109 units & 892 units respectively.
3. Imatinib (100 mg & 400 mg) Tablets/Capsules. The required quantity is 3,315 units & 9,555 units respectively.

Reply

25 Nov 2020

Enquiry// Imatinib, Dasatinib and various other FDFs required in Colombia [ENA00163]

A leading supplier of raw materials, active ingredients, excipients and packaging material for the pharmaceutical, veterinary and agrochemical industries is searching for suppliers of Adalimumab 40 mg/0.8 ml - 50 mg/ml Inj. solution 6000 vials, Infliximab 100 mg 4000 vials, Abatacept 125 mg/ml (4 vials/box) 4000 Boxes, Abatacept 250 mg/ml (4 vials/box), Tocilizumab 200 mg/10 ml 4000 vials, Tocilizumab 80 mg/4 ml 4000 vials, Certolizumab 200 mg/ml 3000 vials, Dasatinib 70 MG (7 tabs/box) 4000 boxes, Imatinib 100 mg (7 tabs/box) 4000 boxes and Imatinib 400 mg (7 tabs/box) 4000 boxes with GMP and dossier support from regulated markets for commercialization in Colombia.

Reply

20 Jan 2017

Out-licensing opportunities // Eurofarma, a market-leader in Brazil is looking for partners to expand into the Mi...

With GMP production facilities, accredited by ANVISA (Brazil), ANMAT (Argentina), INVIMA (Colombia) and DIGEMID (Peru), Eurofarma Laboratorios is searching for partners in Middle East, Africa and Asia. Their export focus is on Moxifloxacin, Esomerprazole, Enoxaparin, Imatinib, Tadalafil, Azithromycin, Doxazosin + Finasteride, Omeprazole injection, Levofloxacin & Paroxetine.View their company profile and entire product list on PharmaCompass at:https://www.pharmacompass.com/api-manufacturers/eurofarma-laboratorios-sa.

Reply

27 Jan 2016